AIHCC
Index Performance
+6.52%
AIHCC
+17.21%
IBB
Overview
Description
The Intelligent Healthcare Conviction strategy (AIHC) uses OpenAI's ChatGPT, Google's Bard, and Inflection AI's Claude to build an equal weighted portfolio of the committee's highest conviction US-listed stocks in the healthcare sector. The strategy aims to create superior quality-focused returns compared to the MSCI US Investable Market Health Care 25/50 Index.
- TickerAIHCC
- Inception Date10/16/2023
- WeightingEqual
- # of holdings30
What's inside?
Holdings
All holdings as of July 26, 2024
CSV download
| ACADIA Pharmaceuticals, Inc. (ACAD) | 4.08% | $3.16B | 73.75% | 88.85% | 3.28 |
| Bristol Myers Squibb Co. (BMY) | 3.88% | $102.27B | 4.66% | 55.54% | 3.46 |
| Universal Health Services, Inc. (UHS) | 3.86% | $12.75B | 10.13% | 11.17% | 1.17 |
| AbbVie, Inc. (ABBV) | 3.70% | $326.97B | 4.31% | 84.95% | N/A |
| Vertex Pharmaceuticals, Inc. (VRTX) | 3.64% | $127.80B | 14.21% | 87.25% | 9.80 |
| HCA Healthcare, Inc. (HCA) | 3.60% | $92.92B | 10.28% | 15.61% | 1.90 |
| Intuitive Surgical, Inc. (ISRG) | 3.57% | $156.82B | 14.47% | 68.30% | 20.59 |
| Pfizer Inc. (PFE) | 3.56% | $174.36B | -18.61% | 70.56% | 3.92 |
| UnitedHealth Group, Inc. (UNH) | 3.55% | $524.36B | 6.61% | N/A | 1.45 |
| Amgen, Inc. (AMGN) | 3.49% | $179.63B | 22.19% | 56.73% | 7.04 |
| Johnson & Johnson (JNJ) | 3.48% | $386.70B | -12.12% | 68.99% | 4.27 |
| Cencora, Inc. (COR) | 3.41% | $45.40B | 7.81% | 3.30% | 0.19 |
| Neurocrine Biosciences, Inc. (NBIX) | 3.40% | $14.77B | 22.57% | 97.52% | 6.87 |
| Zoetis, Inc. (ZTS) | 3.38% | $82.06B | 9.50% | 68.95% | 9.44 |
| Laboratory Corp. of America Holdings (LH) | 3.35% | $17.78B | -15.92% | 26.36% | 1.98 |
| Thermo Fisher Scientific, Inc. (TMO) | 3.35% | $231.76B | -1.37% | 37.21% | 5.63 |
| Danaher Corp. (DHR) | 3.35% | $197.82B | -19.76% | 59.69% | 8.11 |
| Abbott Laboratories (ABT) | 3.32% | $183.08B | 4.00% | 55.96% | N/A |
| Stryker Corp. (SYK) | 3.26% | $126.35B | 9.73% | 60.92% | 7.10 |
| Eli Lilly & Co. (LLY) | 3.26% | $764.72B | 25.98% | 80.91% | 20.23 |
| Henry Schein, Inc. (HSIC) | 3.21% | $9.26B | 3.66% | 29.98% | 1.11 |
| Elevance Health, Inc. (ELV) | 3.15% | $122.32B | -0.06% | N/A | 0.90 |
| Merck & Co., Inc. (MRK) | 3.13% | $317.26B | 8.38% | 75.11% | 5.96 |
| Mettler-Toledo International, Inc. (MTD) | 3.10% | $30.97B | -0.30% | 57.23% | 8.11 |
| Medtronic Plc (MDT) | 3.03% | $100.91B | 3.64% | 60.11% | 3.84 |
| Grifols SA (GRF) | 3.03% | $6.24B | 8.71% | 35.24% | 3.37 |
| IDEXX Laboratories, Inc. (IDXX) | 2.95% | $38.79B | 7.10% | 61.60% | 12.35 |
| ResMed, Inc. (RMD) | 2.94% | $28.95B | 7.17% | 56.94% | 6.57 |
| Align Technology, Inc. (ALGN) | 2.72% | $16.60B | 2.63% | 70.65% | 4.43 |
| Edwards Lifesciences Corp. (EW) | 2.25% | $37.58B | -9.43% | 79.56% | 9.10 |
Market data by FactSet